vs

Side-by-side financial comparison of Ceribell, Inc. (CBLL) and Legacy Housing Corp (LEGH). Click either name above to swap in a different company.

Legacy Housing Corp is the larger business by last-quarter revenue ($25.5M vs $24.8M, roughly 1.0× Ceribell, Inc.). Legacy Housing Corp runs the higher net margin — 32.2% vs -54.6%, a 86.7% gap on every dollar of revenue. Legacy Housing Corp produced more free cash flow last quarter ($15.7M vs $-11.0M).

Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.

Legacy Housing Corp is a prominent U.S.-based manufacturer of affordable manufactured homes, tiny homes, and accessory dwelling units. It mainly caters to low- and middle-income consumers across North America, providing customizable residential solutions, supporting construction materials, and after-sales services for individual and community development clients.

CBLL vs LEGH — Head-to-Head

Bigger by revenue
LEGH
LEGH
1.0× larger
LEGH
$25.5M
$24.8M
CBLL
Higher net margin
LEGH
LEGH
86.7% more per $
LEGH
32.2%
-54.6%
CBLL
More free cash flow
LEGH
LEGH
$26.6M more FCF
LEGH
$15.7M
$-11.0M
CBLL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CBLL
CBLL
LEGH
LEGH
Revenue
$24.8M
$25.5M
Net Profit
$-13.5M
$8.2M
Gross Margin
87.3%
26.4%
Operating Margin
-58.9%
40.4%
Net Margin
-54.6%
32.2%
Revenue YoY
-30.6%
Net Profit YoY
-43.5%
EPS (diluted)
$-0.35
$0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBLL
CBLL
LEGH
LEGH
Q4 25
$24.8M
$25.5M
Q3 25
$22.6M
$28.8M
Q2 25
$21.2M
$38.4M
Q1 25
$20.5M
$24.3M
Q4 24
$36.7M
Q3 24
$17.2M
$30.2M
Q2 24
$31.7M
Q1 24
$30.8M
Net Profit
CBLL
CBLL
LEGH
LEGH
Q4 25
$-13.5M
$8.2M
Q3 25
$-13.5M
$8.6M
Q2 25
$-13.6M
$14.7M
Q1 25
$-12.8M
$10.3M
Q4 24
$14.5M
Q3 24
$-10.4M
$15.8M
Q2 24
$16.2M
Q1 24
$15.1M
Gross Margin
CBLL
CBLL
LEGH
LEGH
Q4 25
87.3%
26.4%
Q3 25
88.3%
20.2%
Q2 25
88.1%
32.4%
Q1 25
87.9%
29.2%
Q4 24
27.3%
Q3 24
87.3%
29.2%
Q2 24
31.9%
Q1 24
33.6%
Operating Margin
CBLL
CBLL
LEGH
LEGH
Q4 25
-58.9%
40.4%
Q3 25
-64.8%
33.7%
Q2 25
-70.5%
43.8%
Q1 25
-69.3%
47.7%
Q4 24
42.3%
Q3 24
-57.8%
50.8%
Q2 24
50.6%
Q1 24
54.3%
Net Margin
CBLL
CBLL
LEGH
LEGH
Q4 25
-54.6%
32.2%
Q3 25
-59.6%
30.0%
Q2 25
-64.4%
38.3%
Q1 25
-62.4%
42.3%
Q4 24
39.5%
Q3 24
-60.6%
52.4%
Q2 24
51.1%
Q1 24
49.1%
EPS (diluted)
CBLL
CBLL
LEGH
LEGH
Q4 25
$-0.35
$0.38
Q3 25
$-0.37
$0.35
Q2 25
$-0.38
$0.60
Q1 25
$-0.36
$0.41
Q4 24
$0.59
Q3 24
$-1.85
$0.64
Q2 24
$0.65
Q1 24
$0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBLL
CBLL
LEGH
LEGH
Cash + ST InvestmentsLiquidity on hand
$159.3M
$8.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$155.3M
$528.6M
Total Assets
$195.8M
$580.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBLL
CBLL
LEGH
LEGH
Q4 25
$159.3M
$8.5M
Q3 25
$168.5M
$13.6M
Q2 25
$177.4M
$2.6M
Q1 25
$182.7M
$3.4M
Q4 24
$1.1M
Q3 24
$14.1M
$570.0K
Q2 24
$60.0K
Q1 24
$621.0K
Stockholders' Equity
CBLL
CBLL
LEGH
LEGH
Q4 25
$155.3M
$528.6M
Q3 25
$164.1M
$521.6M
Q2 25
$172.2M
$512.8M
Q1 25
$180.9M
$503.7M
Q4 24
$494.0M
Q3 24
$-136.0M
$479.3M
Q2 24
$463.2M
Q1 24
$450.4M
Total Assets
CBLL
CBLL
LEGH
LEGH
Q4 25
$195.8M
$580.3M
Q3 25
$199.5M
$557.9M
Q2 25
$207.7M
$552.0M
Q1 25
$213.5M
$544.6M
Q4 24
$534.2M
Q3 24
$47.1M
$521.4M
Q2 24
$514.9M
Q1 24
$510.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBLL
CBLL
LEGH
LEGH
Operating Cash FlowLast quarter
$-10.8M
$19.0M
Free Cash FlowOCF − Capex
$-11.0M
$15.7M
FCF MarginFCF / Revenue
-44.2%
61.6%
Capex IntensityCapex / Revenue
0.7%
13.1%
Cash ConversionOCF / Net Profit
2.32×
TTM Free Cash FlowTrailing 4 quarters
$-41.6M
$28.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBLL
CBLL
LEGH
LEGH
Q4 25
$-10.8M
$19.0M
Q3 25
$-11.1M
$7.2M
Q2 25
$-7.5M
$6.1M
Q1 25
$-11.4M
$4.9M
Q4 24
$7.9M
Q3 24
$13.8M
Q2 24
$3.5M
Q1 24
$10.8M
Free Cash Flow
CBLL
CBLL
LEGH
LEGH
Q4 25
$-11.0M
$15.7M
Q3 25
$-11.5M
$5.1M
Q2 25
$-7.6M
$3.7M
Q1 25
$-11.6M
$3.6M
Q4 24
$6.0M
Q3 24
$9.1M
Q2 24
$1.7M
Q1 24
$9.9M
FCF Margin
CBLL
CBLL
LEGH
LEGH
Q4 25
-44.2%
61.6%
Q3 25
-50.8%
17.8%
Q2 25
-35.9%
9.6%
Q1 25
-56.4%
15.0%
Q4 24
16.4%
Q3 24
30.2%
Q2 24
5.4%
Q1 24
32.2%
Capex Intensity
CBLL
CBLL
LEGH
LEGH
Q4 25
0.7%
13.1%
Q3 25
1.6%
7.1%
Q2 25
0.3%
6.2%
Q1 25
0.7%
5.2%
Q4 24
5.1%
Q3 24
15.6%
Q2 24
5.5%
Q1 24
2.8%
Cash Conversion
CBLL
CBLL
LEGH
LEGH
Q4 25
2.32×
Q3 25
0.83×
Q2 25
0.41×
Q1 25
0.48×
Q4 24
0.54×
Q3 24
0.88×
Q2 24
0.21×
Q1 24
0.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBLL
CBLL

Products$18.8M76%
Subscription$6.0M24%

LEGH
LEGH

Commercial Sales$8.6M34%
Retail Store Sales$6.0M24%
Inventory Finance Sales$5.0M20%
Direct Sales$4.4M17%
Other$1.5M6%

Related Comparisons